The role of sialidase in the development of hypocomplementemia in postinfectious acute glomerulonephritis

Clinical Immunology

Volumn 92, Issue 1, 1999, Pages 97-102

  Fujita, Takayuki ^a   Ohi, Hiroyuki ^a   Endo, Morito ^a   Ohsawa, Isao ^a   Kanmatsuse, Katsuo ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute glomerulonephritis; Complement; Neuraminidase; Sialic acid; Sialidase

Indexed keywords

COMPLEMENT COMPONENT C3B; SIALIDASE;

ACUTE GLOMERULONEPHRITIS; ARTICLE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYPOCOMPLEMENTEMIA; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0032977456     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4729     Document Type: Article

References (27)

1. Hinglais N., Grunfeld J., Garcia-Torres R. Acute glomerulonephritis. Hamburger J. Nephrology. 1979;455-474 Wiley/Flammarion, Paris.
2. Leibowitch L., Halwachs M., Wattel S. Glomerulonephritides and hypocomplementemia: Pathophysiology and pathogenic implications. Hamburger J. Advances in Nephrology. 1980;295-314 Year Book Med. Pub. Chicago.
3. Glassock R. J. Clinical features of immunologic glomerular disease. Wilson C. B. Immunologic Mechanisms of Renal Disease. 1979;165-179 Churchill Livingstone, London.
4. Jordan S. C., Leire J. M. Acute glomerulonephritis. Pediatr. Clin. North Am. 29:1983;857-873.
5. Williams D. G., Kourilsky O., Morel-Maroger L., Peters D. K. C3 breakdown by serum from patients with acute poststreptoccoal nephritis. Lancet. II:1972;360-361.
6. Schena F. P., Pertosa G., Vox E., Bonomo L. Activation of the alternative complement pathway by unidentified substances in human glomerulonephritis. Nephron. 27:1981;9-14.
7. Fujita T., Ohi H., Seki M., Hatano M. Clinical evaluation and characterization of a unique C3 breakdown factor detected in a patient with acute glomerulonephritis. Nephron. 47:1987;56-61.
8. Rodriguez-Iturbe B., Katiyar V. N., Coello J. Neuraminidase activity and free sialic acid levels in the serum of patients with acute poststreptococcal glomerulonephritis. N. Engl. J. Med. 304:1981;1506-1510.
9. Harrison R. A., Lachmann P. J. Complement technology. Weir D. M. Handbook of Experimental Immunology. 1986;5A.1-23.10 Blackwell Sci. Oxford.
10. Meguro T., Yamada K. Assay of neuraminidase activity in plasma with synthetic fluorescent chromogenic substrate. Jpn. J. Inflam. 3:1983;47-50.
11. Hammond K. S., Papermaster D. S. Fluorometric assay of sialic acid in the picomole range: A modification of the thiobarbituric acid assay. Anal. Biochem. 74:1976;292-297.
12. Sugahara K., Sugimotyo K., Nomura O., Usui T. Enzymatic assay of serum sialic acid. Clin. Chim. Acta. 108:1980;493-498.
13. Mancini G., Carbonara A., Hermans J. Immunological quantitation of antigens by single radial immunodiffusion. Immunochemistry. 2:1965;235-253.
14. Tamerius J. D., Pangburn M. K., Müller-Eberhard H. J. Detection of a neoantigen on human C3bi and C3d by monoclonal antibody. J. Immunol. 135:1985;2015.
15. Kolb W. P., Morrow P. R., Tamerius J. D. Ba and Bb fragments of Factor B activation: Fragment production, biological activities, neoepitope expression and quantitation in clinical samples. Complement Inflam. 6:1989;175-204.
16. Hess E. L., Coburn A. F., Bates R. C., Murphy P. A new method for measuring sialic acid levels in serum and its application to rheumatic fever. J. Clin. Invest. 36:1957;449-455.
17. Warren L. The distribution of sialic acid in nature. Comp. Biochem. Physiol. 10:1978;153-171.
18. Fujita T., Ohi H., Seki M., Hatano M. Hemolytic activity of Factor B and Factor D of alternative complement pathway in patients with various primary glomerulonephritis. Jpn. J. Nephrol. 23:1981;663-664.
19. Matsushita M. The lectin pathway of the complement system. Microbiol. Immunol. 40:1996;887-893.
20. Schweinle J. E., Ezekowitz R. A. B., Tenner A. J., Kuhlman M., Joiner K. A. Human mannose-binding protein activates the alternative complement pathway and enhances serum bacterial activity on a mannose-rich isolate of salmonella. J. Clin. Invest. 84:1989;1821-1829.
21. Budzko D. B., Lachmann P. J., McConnell I. Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis. Cell. Immunol. 22:1976;98-109.
22. Schreiber R. D., Pangburn M. K., Medicus R. G., Müller-Eberhard H. J. Raji cell injury and subsequent lysis by the purified cytelytic alternative pathway of human complement. Clin. Immunol. Immunopathol. 15:1980;384-396.
23. Fearon D. T. Regulation by membrane sialic acid of β1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. Proc. Natl. Acad. Sci. USA. 75:1978;1971-1975.
24. Pangburn M. K., Müller-Eberhard H. J. Complement C3 covertase: Cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells. Proc. Natl. Acad. Sci. USA. 75:1978;2416-2420.
25. Lambre C. R., Thibon M., Maho S. L., Bella G. D. Auto-antibody dependent activation of the autologous classical complement pathway by guinea-pig red cells treated with influenza virus or neuraminidase: In vitro and in vivo study. Immunology. 49:1983;311-319.
26. Markham R. B., Nicholson-Weller A., Schiffman G., Kasper D. L. The presence of sialic acid on two related bacterial polysaccharides determines the site of the primary immune response and the effect of complement depletion on the response in mice. J. Immunol. 128:1982;2731-2733.
27. Ohi H., Seki M., Sakashita T., Hatano M. Guinea pig complement fixation by tissues from hypocomplementaemic renal diseases. Clin. Immunol. Immunopathol. 39:1986;93-101.